Atypical Antipsychotics in Major Depressive Disorder

Article

Atypical Antipsychotics in Major Depressive Disorder:

When Current Treatments Are Not Enough

Related Videos
Related Content
Phase 2 SAVITRI Supports Use of NBI-1065845 in Major Depressive Disorder with Inadequate Response to Antidepressants ||| Depressed man on floor. | Credit: HolgersFotografie | Pixabay

Phase 2 SAVITRI Supports Use of NBI-1065845 in Major Depressive Disorder with Inadequate Response to Antidepressants

April 23rd 2024
Article
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

April 17th 2024
Podcast
Safia Chatur, MD | Credit: X.com

Safia Chatur, MD: Sacubitril/Valsartan Offers Benefit in HFrEF Across New KDIGO Risk Classes

April 12th 2024
Article
"New Insight with Veeral Sheth, MD" logo | Image Credit: HCPLive

New Insight: Role of Contract Research Organizations in Retina w/ Brad Doerschuk

February 29th 2024
Podcast
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University

Understanding Trends in Hypertrophic Cardiomyopathy-Related ED Visits, with Ahmad Masri, MD, MS

April 12th 2024
Article
Deepak Bhatt, MD, MPH, MBA | Credit: Mount Sinai Heart

ACC.24 Clinical Trials Recap, with Deepak Bhatt, MD, MPH, MBA

April 11th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.